+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

DMT-dG Phosphoramidite Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6117037
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The DMT-dG phosphoramidite market has become a cornerstone for decision-makers navigating high-stakes oligonucleotide research, diagnostics, and clinical development. As organizations confront supply chain complexities and evolving quality requirements, this sector demands agile procurement and strategic vendor management to support long-term innovation.

Market Snapshot: DMT-dG Phosphoramidite Market Performance

The DMT-dG phosphoramidite market expanded from USD 154.02 million in 2025 to USD 167.45 million in 2026 and is projected to reach USD 277.16 million by 2032, advancing at a CAGR of 8.75%. This significant growth underscores the compound’s pivotal role in oligonucleotide synthesis, anchored by mounting demand in therapeutic development, advanced diagnostics, and multi-disciplinary research. As the sector matures, procurement and R&D teams increasingly focus on quality reagents that meet stringent compliance needs and the scalability required for advanced nucleic acid applications.

DMT-dG Phosphoramidite Market: Scope & Segmentation

  • Applications: Clinical programs encompassing preclinical and clinical trial phases, as well as diagnostics and research settings, each with unique standards for quality, data reporting, and compliance.
  • End-User Types: Academic and research institutes utilize these reagents for fundamental studies; Contract Research Organizations deliver both analytical and synthetic services to external clients; Pharmaceutical and biotechnology companies drive translational and commercial applications.
  • Purity Grades: Options include high, standard, and ultra-high purity grades, with ultra-high further divided into HPLC and RP-HPLC purified for demanding impurity profiles and strict batch validation processes.
  • Synthesis Scales: Bulk, gram, and multigram production, each scale requiring tailored procurement protocols, specialized storage, and differentiated cost controls.
  • Synthesis Technologies: Solid-phase and liquid-phase oligonucleotide synthesis, each offering specific advantages in reagent compatibility, solvent management, and process efficiency under regulatory guidelines.
  • Regions: Americas benefit from established regulatory practices and predictable demand; Europe, Middle East, and Africa prioritize harmonized documentation; Asia-Pacific stands out for large-scale manufacturing capacity and surging research investment.

Strategic Relevance by Segment

Every segment—whether clinical, research, or diagnostic—relies on reliable DMT-dG phosphoramidite sources for workflow continuity. End-users in regulated markets, such as pharmaceuticals, emphasize validated purity grades and supplier transparency, while academic labs may prioritize cost and technical support. Rapid evolution in synthesis technologies fuels continuous reassessment of supplier capabilities, particularly for CROs managing diverse client requirements.

DMT-dG Phosphoramidite: Key Takeaways for Strategic Procurement

  • Supplier qualification requires a careful balance between reproducibility, proven quality, and visibility into supply chains, all crucial for programs with tight regulatory and delivery timelines.
  • Progress in synthesis and purification techniques elevates expectations for reagent grades, especially as projects transition through preclinical, clinical, and diagnostic phases.
  • Contract Research Organizations streamline analytical and synthetic workflows, reducing overall project lead times and supporting robust documentation for compliance.
  • Flexible inventory practices and sourcing from multiple suppliers have become standard, offering necessary protection against disruptions caused by logistics or market fluctuations.
  • Engaged partnerships between suppliers and buyers enable better risk management and facilitate adaptation to project-specific requirements in terms of lead times and impurity thresholds.

Tariff Impact: Navigating Policy-Driven Procurement Complexity

Recent changes to U.S. tariffs have altered sourcing strategies, with procurement teams now accounting for duties in supplier evaluations. Organizations are leveraging regional manufacturing, bonded inventory, and diversified vendor qualification to counteract cost variability and maintain reliable access to essential reagents. These adaptive strategies safeguard ongoing programs dependent on high-quality materials like DMT-dG phosphoramidite.

Methodology & Data Sources

This analysis draws on structured interviews with procurement leads, synthetic chemists, and regulatory experts. Supplementary review of technical bulletins, peer-reviewed publications, and regulatory guidance, as well as detailed supplier data comparisons and scenario modeling, ensures the report’s actionable value.

Why This Report Matters for Senior Decision-Makers

  • Clarifies technical and compliance factors driving global sourcing, empowering executives to build risk-aware procurement strategies aligned with organizational growth.
  • Supports effective collaboration across quality management, supply chain, and development teams to enhance supplier resilience and ensure program stability.
  • Provides actionable recommendations for harmonizing inventory, purity selection, and supplier relationships across research, diagnostics, and clinical applications.

Conclusion

Adapting DMT-dG phosphoramidite sourcing and supplier management is essential for program integrity amid industry change. This report equips leaders to align procurement, inventory, and quality standards for sustained oligonucleotide innovation and regulatory compliance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. DMT-dG Phosphoramidite Market, by Purity Grade
8.1. High Purity
8.2. Standard Purity
8.3. Ultra High Purity
8.3.1. HPLC Purified
8.3.2. RP-HPLC Purified
9. DMT-dG Phosphoramidite Market, by Synthesis Scale
9.1. Bulk Scale
9.2. Gram Scale
9.3. Multigram Scale
10. DMT-dG Phosphoramidite Market, by Technology
10.1. Liquid-Phase Oligonucleotide Synthesis
10.2. Solid-Phase Oligonucleotide Synthesis
11. DMT-dG Phosphoramidite Market, by Application
11.1. Clinical
11.1.1. Clinical Trial
11.1.1.1. Phase I
11.1.1.2. Phase II
11.1.1.3. Phase III
11.1.2. Preclinical
11.2. Diagnostics
11.3. Research
12. DMT-dG Phosphoramidite Market, by End-User
12.1. Academic & Research Institutes
12.2. Contract Research Organizations
12.2.1. Analytical Services
12.2.2. Synthetic Services
12.3. Pharmaceutical & Biotechnology Companies
13. DMT-dG Phosphoramidite Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. DMT-dG Phosphoramidite Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. DMT-dG Phosphoramidite Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States DMT-dG Phosphoramidite Market
17. China DMT-dG Phosphoramidite Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AAT Bioquest, Inc.
18.6. Agilent Technologies, Inc.
18.7. BioAutomation Corporation
18.8. Biosynth Carbosynth
18.9. BOC Sciences
18.10. BroadPharm
18.11. Carbosynth Ltd.
18.12. Cayman Chemical Company
18.13. ChemGenes Corporation
18.14. Combi-Blocks Inc.
18.15. Enamine Ltd.
18.16. Fluorochem Ltd.
18.17. Glen Research Corporation
18.18. Hello Bio Ltd.
18.19. LGC Limited
18.20. Merck KGaA
18.21. Thermo Fisher Scientific Inc.
18.22. Tokyo Chemical Industry Co., Ltd.
List of Figures
FIGURE 1. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY HIGH PURITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY HIGH PURITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY HIGH PURITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY STANDARD PURITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY STANDARD PURITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY STANDARD PURITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY HPLC PURIFIED, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY HPLC PURIFIED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY HPLC PURIFIED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY RP-HPLC PURIFIED, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY RP-HPLC PURIFIED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY RP-HPLC PURIFIED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY BULK SCALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY BULK SCALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY BULK SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY GRAM SCALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY GRAM SCALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY GRAM SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY MULTIGRAM SCALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY MULTIGRAM SCALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY MULTIGRAM SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY LIQUID-PHASE OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY LIQUID-PHASE OLIGONUCLEOTIDE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY LIQUID-PHASE OLIGONUCLEOTIDE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ANALYTICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ANALYTICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHETIC SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHETIC SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHETIC SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 124. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 128. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 148. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 149. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 150. AFRICA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 165. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 169. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 170. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 171. ASEAN DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 172. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 174. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 175. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 176. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 179. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 180. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 181. GCC DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 192. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 194. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 195. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 196. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 199. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 200. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 201. BRICS DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 202. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 204. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 205. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 206. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 209. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 210. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 211. G7 DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 212. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 214. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 215. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 216. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 219. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 220. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 221. NATO DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 233. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 235. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY ULTRA HIGH PURITY, 2018-2032 (USD MILLION)
TABLE 236. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY SYNTHESIS SCALE, 2018-2032 (USD MILLION)
TABLE 237. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 238. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
TABLE 240. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 241. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 242. CHINA DMT-DG PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)

Companies Mentioned

  • AAT Bioquest, Inc.
  • Agilent Technologies, Inc.
  • BioAutomation Corporation
  • Biosynth Carbosynth
  • BOC Sciences
  • BroadPharm
  • Carbosynth Ltd.
  • Cayman Chemical Company
  • ChemGenes Corporation
  • Combi-Blocks Inc.
  • Enamine Ltd.
  • Fluorochem Ltd.
  • Glen Research Corporation
  • Hello Bio Ltd.
  • LGC Limited
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.

Table Information